Wednesday, January 24, 2018
News
NEWS HOME
»
PRESS RELEASES

SMT (Sahajanand Medical Technologies) Raises INR 230 Crores of Equity Capital in a Round Led by a Fund Managed by Morgan Stanley Private Equity Asia
  SocialTwist Tell-a-Friend  
   


Date: 12-01-2018 5:45PM
Source: Sahajanand Medical Technologies Pvt. Ltd. (SMT)
Category: Business/ Finance, Financial Analyst & Investors, Medical Devices, General, Consumer Interest, Govt. & Public Policy, Start Up, Financial Analyst & Investors, Healthcare & Biotechnology, Advertising, Pr And Marketing, Manufacturing Companies, Sme
Location: Mumbai, Maharashtra, India

Business Wire India
SMT, the leading manufacturer of cardiac stents in India, is pleased to announce that it has successfully raised equity to the tune of Rs. 230 crore in a funding round led by Morgan Stanley Private Equity Asia. Existing Investor Samara Capital also participated in the round.

Founded by Mr. Dhirajlal Kotadia in 2001, SMT became an early champion of the ‘Make in India’ initiative by being one of the first companies in Asia to indigenously develop & manufacture coronary stents. Today, SMT is the largest developer, manufacturer and market leader of minimally invasive coronary stents (drug-eluting & bare metal), renal stents, PTCA balloon catheters and other cardiovascular accessories in India. Beyond India, SMT also exports its portfolio of life-saving devices to UK, Spain, Italy, Netherlands & over 60 other countries.

SMT operates a WHO-GMP certified manufacturing plant in Gujarat and two world-class R&D centers, including one in Ireland. The Company has a strong focus on R&D and has a number of pioneering achievements to its credit including being the first company in the world to receive the CE certification for a drug eluting stent with biodegradable polymer. Further, SMT has published several clinical studies in leading cardiac journals and has multiple process/product patents. The company keeps a highly customer-centric approach while distributing its innovative products & technologies through a well-entrenched direct sales network.

As part of the current transaction, a fund managed by Morgan Stanley Private Equity Asia has invested INR 160cr in primary capital into the Company for a minority stake. SMT’s existing institutional investor, Samara Capital also participated in the round. KPMG India Private Limited served as an exclusive financial advisor to SMT for the transaction.

The proceeds from the transaction will be used to finance SMT’s strong organic growth, achieve synergistic acquisitions and build an aggressive R&D program for a further expansion of its portfolio of innovative lifesaving medical devices.

Speaking on the transaction, Bhargav Kotadia, Managing Director of SMT, remarked, “We are proud to partner with a pedigree investor like Morgan Stanley Private Equity Asia in our journey of becoming a global leader of cardiovascular devices. The proceeds from this investment round will bolster further expansion in overseas markets and assist in building our pipeline of next generation cardiovascular products. As proud early champions of ‘Make in India’, we look forward to making India a global powerhouse for critical medical devices in the near future.”

Arjun Saigal, Co-head of Morgan Stanley Private Equity Asia in India, said, “Lifesciences & Healthcare is one of our core focus sectors in India. The increasing burden of lifestyle diseases combined with the push towards local manufacturing backed by the best in class R&D has led to a significant rise in the use of domestic medical implants. SMT’s high-end technology and focus on R&D will make it a key beneficiary of the rapid expansion in treatment volumes and medical infrastructure. We are excited to be partnering with SMT in its journey forward.”

SMT is a professionally run, technology-driven company with products far superior to its peers and is all set to make a mark at the global level as a leading cardiovascular focused medical devices company from India. Samara’s investment in late 2016 was a result of the high potential we saw in the sector and capabilities within SMT to emerge as the market leader. The new up-round and fund raise validates our thesis and further strengthens the balance sheet of the company.” adds Abhishek Kabra, Director at Samara Capital.
About SMT

Established in 2001, and headquartered in Gujarat, SMT is the largest developer and manufacturer of precision engineered cardiac products in India. The Company has a wide product portfolio, including coronary stents (drug-eluting and bare-metal), renal stents, PTCA balloon catheters and other cardiac accessories in India and abroad. SMT has a manufacturing facility in the special economic zone in Surat in Gujarat and a R&D center in Dublin, Ireland. SMT is ISO 9001, ISO 13485, ANVISA and WHO-GMP certified. The Company’s products are CE certified. SMT is part of the Sahajanand Group of Companies (for more information, please visit http://smtpl.com/).

About Morgan Stanley Private Equity Asia

Morgan Stanley Private Equity Asia (“MSPEA”) is one of the leading private equity investors in Asia-Pacific, having invested in the region for over 20 years. MSPEA invests primarily in highly structured minority investments and control buyouts in growth-oriented companies. The experienced investment team is led by senior professionals with extensive industry relationships, in-depth market knowledge and the ability to apply international investment principles within each local context.

MSPEA has offices in Hong Kong, Beijing, Shanghai, Seoul, Tokyo, Mumbai and New York, and leverages the brand and unparalleled global network of Morgan Stanley.

About Samara Capital

Samara Capital is an entrepreneurially run India focused private equity firm. Samara invests in Emerging Indian Companies (EICs) – which it defines as those businesses that are poised for rapid transformation, have strong entrepreneurial minded management team and a favorable industry context. Samara has been investing in India since 2007 as a sector agnostic firm and has so far made over 20 investments with a high focus on consumer, healthcare and business services sectors.


More Press Releases

International Research Organization Honors Health Care Fraternity for their Outstanding Work

TRAVELSPICE Wins Travel-tech Startup of the Year 2018 Award and Grant of Rs 15 lakhs from Government of Karnataka

Win 2 lakhs this Patriotic Day at Adda52 Rummy in Republic Day Tournament

IDEMIA Announces Acquisition of Otono Networks and Its eSIM Orchestration Solution

Global Eagle to Elevate Airline Passenger Experience Over North America with More SES HTS Satellite Capacity

Augmont adds 500,000 Offline Touch Points to its Net, Spreads Wings to Smaller Towns

Neil Diamond Announces Retirement from Concert Touring; Australian and New Zealand Tour Dates Cancelled

AECOM defines infrastructure’s next chapter with launch of its inaugural global report: The Future of Infrastructure

Takeda Recognized as a Global 100 Most Sustainable Corporation for Third Consecutive Year

Tata Housing Launches 'Vertillas' Ultra-luxury Residences at Primanti in Gurugram

PMI’s Salary Survey Reveals that Project Management Practitioners with the PMP Certification Earn 23% More

Bacardi to Acquire Patrón Tequila

BMW India Announces an Exclusive Partnership with Bengaluru International Airport

Häfele Unites Design Possibilities with Form and Functionality at its New State-of-the-art Showroom in Bangladesh

IC3 Announces the Third Edition of the 2018 Annual IC3 Conference to Provide an Impetus to Career Counseling in High Schools

Large Deals across Multiple Verticals Drive a 26 percent YoY USD Revenue Growth for L&T Technology Services

Commvault Powers New HPE GreenLake Backup Solution to Bring Enterprise-class Data Protection and Reliability to Customers

European Commission Approves ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy– Providing an Innovative Treatment Option to Patients

Hilton Led Hospitality Industry in Customer Innovations and Recorded Best Ever Growth in 2017

HackerEarth Recruit Continues Exceptional Customer Momentum; Used by More than 4000 Enterprises

MAIT Strongly Advocates "Make in India for the World" through its Electronics Manufacturing Summit

Calvin Klein, Inc. Announces the Spring/Summer 2018 Calvin Klein Underwear and Calvin Klein Jeans Global Advertising Campaign

Ferring enters into worldwide OmniAb® platform license agreement with Ligand

Hybrid and Electric Vehicle Growth in India Driven by Government Incentives and Changing Customer Attitudes

Panasonic LUMIX GH5 Supports Yasunaga Ogita, a Polar Explorer, in Japan's First Solo South Pole Expedition Without Resupplies

Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India

New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients

Octapharma:Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Treamis World School Marks its Decennial Celebrations in Style!

Green Initiatives in India to be Recognized at the One Globe Awards

Dailyhunt Launches Newzly, a News-in-Brief App, in Nine Languages

Jaipuria Group Plans to Invest 500 crores for Expansion across 5 States

 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
'Odisha Bandh' to protest suicide of K...
World Cup arrives in Sri Lanka to kick o...
How cruise vacations are good for your w...
Udacity announces 'Flying Cars Nanodegre...
Dilip Buildcon declared L-1 bidder for N...
JMC Projects Secures new orders worth Rs...
More...    
 
 Top Stories
Haqqani network commander, two othe... 
Marketing tech firm Netcore expands... 
Lalu Prasad, Jagannath Mishra get 5... 
India reach 45/2 at lunch on Day 1... 
Military bands to hit the right not... 
Equities scale new highs amid flat ... 
Bankers suggest lowering corporate ... 
At Disneyland Paris, age is just a ...